Insider filing · RARE
Thomas Richard Kassberg
CBO & EVP
profile →
Ultragenyx Pharmaceutical Inc.
RARE · Healthcare · 27 filings in 24 months
ticker →
Thomas Richard Kassberg sold $254K of Ultragenyx Pharmaceutical (RARE)
Executed Mar 3 2025, disclosed Mar 4 2025, 1 day later.
Value, as filed
$254K
6,028 sh × $42.10
Executed
Mar 3 2025
the trade date, as filed
Disclosed
Mar 4 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TKThomas Richard Kassberg (CBO & EVP) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $254K of RARE (6,028 sh × $42.10, as filed), executed Mar 3 2025.
The name
RAREHealthcare · Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→